Patrizia Ghidotti
Overview
Explore the profile of Patrizia Ghidotti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
12
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ghidotti P, Petraroia I, Fortunato O, Pontis F
Extracell Vesicles Circ Nucl Acids
. 2024 Dec;
4(1):59-71.
PMID: 39698297
Lung cancer is the deadliest cancer worldwide, primarily because of its metastatic spread. Extracellular vesicles (EVs) are small lipid-bilayer particles released by almost all types of cells. EVs play fundamental...
2.
Petraroia I, Ghidotti P, Bertolini G, Pontis F, Roz L, Balsamo M, et al.
Cell Death Dis
. 2023 Oct;
14(10):681.
PMID: 37838700
Chronic obstructive pulmonary disease (COPD) is a risk factor for lung cancer development. COPD induces activation of hypoxia-induced signaling, causing remodeling of surrounding microenvironmental cells also modulating the release and...
3.
Casanova M, Pontis F, Ghidotti P, Petraroia I, Venturini L, Bergamaschi L, et al.
Int J Mol Sci
. 2022 Nov;
23(22).
PMID: 36430468
Adolescents and young adults (AYA) with rhabdomyosarcoma (RMS) form a subgroup of patients whose optimal clinical management and best possible access to care remain a challenge and whose survival rates...
4.
Signorelli D, Ghidotti P, Proto C, Brambilla M, De Toma A, Ferrara R, et al.
Front Immunol
. 2022 Oct;
13:987639.
PMID: 36203609
PD-L1 in tumor cells is the only used biomarker for anti PD1/PD-L1 immune-checkpoints inhibitors (ICI) in Non Small Cell Lung Cancer (NSCLC) patients. However, this parameter is inaccurate to predict...